Vertical: CNMBase Year: 2025
Market Size (2025)
$193.10M
Projected (2032)
$252.40M
CAGR (2022–2032)
4.4%
Key Players
11+
Market Overview
The Global Octofluoropropane Market was valued at USD 193.10 Million in 2025 and is projected to reach USD 252.40 Million by 2032, registering a CAGR of 3.82% over the forecast period 2026–2032. The market has expanded steadily from USD 164.36 Million in 2022, and is expected to add USD 59.30 Million in absolute terms between 2025 and 2032. Octafluoropropane (C3F8, also designated PFC-218, R-218 and, in pharmaceutical nomenclature, perflutren) is a fully fluorinated, chemically inert, non-flammable gas whose commercial value is concentrated in two highly specified end uses: plasma etching and chamber cleaning in semiconductor fabrication, and gas-filled microsphere contrast agents for diagnostic ultrasound.
Demand is anchored by the semiconductor industry, where C3F8 is used as a fluorocarbon etchant for silicon dioxide and other dielectric films and as a chamber-cleaning gas for chemical vapour deposition (CVD) tools. Capacity additions for logic, memory and specialty devices across Asia Pacific, the United States and Europe, supported by large public incentive programmes, sustain consumption of high-purity electronic specialty gases. The medical imaging segment, built on perflutren-based ultrasound enhancing agents used in echocardiography and other diagnostic procedures, provides a stable, regulated and less cyclical demand stream. Smaller volumes are consumed in refrigerant blends, intraocular gas tamponade for retinal surgery, dielectric and specialty uses.
Key Findings
By Application: Semiconductor Etching is the largest segment, accounting for 60.0% of the market in 2025 (USD 115.86 Million). It is also the fastest-growing segment, with a CAGR of 4.15% over 2026–2032.
By Purity: 5N & Above grade C3F8 leads with a 70.0% share in 2025 (USD 135.17 Million) and is also the fastest-growing grade, at a CAGR of 4.23%.
By Region: Asia Pacific is the leading region, holding 80.0% of global revenue in 2025 (USD 154.48 Million). Middle East & Africa is the fastest-growing region, with a CAGR of 5.51%, followed closely by Latin America (CAGR 5.45%).
By Country: China is the leading individual country market, valued at USD 50.98 Million in 2025 (33.0% of Asia Pacific). India is the fastest-growing country, expanding at a CAGR of 7.23% over 2026–2032.
Growth increment: The market is expected to add USD 59.30 Million between 2025 and 2032, of which Semiconductor Etching contributes USD 39.11 Million and Asia Pacific contributes USD 48.78 Million.
Segmentation Summary
The market is analysed by application (Semiconductor Etching; Medical Imaging (Ultrasound Contrast); Others), by purity (5N & Above; Below 5N) and by region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), with country-level coverage of 20 country and sub-regional markets. Semiconductor Etching accounted for USD 115.86 Million in 2025 and Medical Imaging (Ultrasound Contrast) for USD 57.93 Million, while the Others segment stood at USD 19.31 Million. The purity split closely mirrors the application split: the 5N & Above grade, which is required for device-level etching at advanced nodes, generated USD 135.17 Million in 2025, compared with USD 57.93 Million for the Below 5N grade, which serves cleaning, pharmaceutical-grade precursor and industrial uses with less stringent impurity limits.
Competitive Landscape Summary
The market is moderately consolidated. Global industrial gas and electronic materials companies, led by Linde, Air Liquide, Merck KGaA (EMD Electronics) and Nippon Sanso Holdings, dominate supply of electronic-grade C3F8 to leading-edge fabs through broad specialty gas portfolios, long-term contracts and on-site presence at major fab clusters. Resonac and Messer are established challengers with strong fluorine chemistry and high-purity capabilities, while Chinese producers such as PERIC Special Gases and Guangdong Huate Gas are rapidly adding high-purity C3F8 capacity under import-substitution policies. Niche suppliers including TEMC in South Korea, EFC Gases & Advanced Materials in the United States and HaloPolymer in Russia serve specific customer groups and regions. Recent strategic activity has centred on capacity expansion near new fabs, acquisitions in Asian electronics hubs and investment in advanced electronic materials, with competition based on purity, supply security, technical service and price.
Challenges and Opportunities
The principal challenge for the market is regulatory pressure on perfluorocarbons. C3F8 has a 100-year global warming potential of approximately 8,900 under the IPCC Fifth Assessment Report and an atmospheric lifetime of about 2,600 years, which places it within greenhouse gas reporting programmes, the European Union F-gas framework and the scope of the proposed European restriction on per- and polyfluoroalkyl substances (PFAS). Semiconductor manufacturers have committed to absolute emission reduction targets, encouraging abatement, process optimisation and, in some cleaning applications, substitution with nitrogen trifluoride (NF3) remote plasma cleaning. Supply-side challenges include concentration of fluorspar and hydrogen fluoride feedstock in a limited number of countries, energy-intensive purification and the cost of cylinder logistics and qualification.
Opportunities arise from new fabrication capacity in the United States, Japan, Europe, India and China, where every new fab must qualify local or regional supply of electronic specialty gases. Localisation policies favour suppliers able to build purification, filling and analytical capability close to customers. In healthcare, growing use of contrast-enhanced echocardiography and contrast-enhanced ultrasound in emerging markets broadens demand for pharmaceutical-grade perflutren, while ultra-high-purity grades with tighter metal and moisture specifications command premium pricing.
Future Outlook
Over 2026–2032 the market is expected to grow from USD 201.56 Million to USD 252.40 Million. Growth will remain led by Asia Pacific and by the 5N & Above grade, with semiconductor etching expanding at 4.15% annually compared with 3.38% for medical imaging. Smaller markets in the Middle East & Africa and Latin America will record the highest growth rates from a low base. Suppliers that combine high-purity production, emission-abatement support for customers and regional supply security are best placed to capture the incremental USD 59.30 Million expected over 2025–2032.
The Octofluoropropane Market market is projected to grow at a CAGR of 4.4% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Octafluoropropane (chemical formula C3F8; CAS No. 76-19-7) is a saturated perfluorocarbon in which all hydrogen atoms of propane are replaced by fluorine. It is a colourless, odourless, non-flammable and chemically stable gas with a molecular weight of about 188 g/mol and a boiling point of approximately −36.7 °C, supplied as a liquefied compressed gas in cylinders, ton containers and ISO tubes. In the electronics industry it is known as PFC-218 or simply C3F8; in refrigeration it carries the designation R-218; and in pharmaceutical use the gas is referred to as perflutren.
For the purpose of this study, the Global Octofluoropropane Market comprises the revenue generated from the sale of octafluoropropane gas of all purity grades to end users and intermediate processors, measured at the producer/supplier level in USD Million. The market includes: (i) electronic-grade C3F8 used for plasma etching of dielectric layers and for in-situ cleaning of CVD and etch chambers; (ii) pharmaceutical-grade C3F8 supplied to manufacturers of perflutren-based ultrasound contrast agents; and (iii) C3F8 used in other applications such as refrigerant blends, intraocular gas tamponade, dielectric insulation, tracer and specialty laboratory uses. The market excludes the value added by finished contrast-agent drug products, semiconductor process equipment, gas abatement systems, other perfluorocarbons (such as CF4, C2F6, c-C4F8, C4F6 and C5F8), hydrofluorocarbons and nitrogen trifluoride, and cylinder rental or on-site gas management service fees billed separately from the gas.
Scope of the Study
The study covers the global market for octafluoropropane with the following scope:
By Application: Semiconductor Etching; Medical Imaging (Ultrasound Contrast); Others.
By Purity: 5N & Above; Below 5N.
By Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA).
Timeline: Historic years 2022, 2023 and 2024; base year 2025; forecast years 2026–2032; CAGR calculated for 2026–2032.
Unit: Market value in USD Million.
Research Objectives
To estimate the size of the global octafluoropropane market in value terms for 2022–2025 and forecast it for 2026–2032.
To quantify demand from semiconductor etching, medical imaging (ultrasound contrast) and other applications, and identify the fastest-growing application.
To assess the demand split between 5N & Above and Below 5N purity grades and the impact of advanced-node semiconductor manufacturing on high-purity demand.
To analyse regional and country-level demand across 5 regions and 20 country and sub-regional markets, linking growth to fab investment and healthcare imaging trends.
To evaluate the effect of greenhouse gas, F-gas and PFAS regulations on C3F8 production, use, emissions abatement and substitution.
To map the value chain from fluorspar and hydrogen fluoride through synthesis, purification, filling and distribution to end users.
To profile the competitive landscape, including the positioning, portfolios and strategic developments of leading producers and suppliers since 2022.
To identify investment opportunities, supply risks and strategic priorities for producers, distributors and end users through 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process. The first stage defined the market, its boundaries and segmentation. The second stage involved extensive secondary research to build an understanding of production capacity, trade flows, regulation, technology and end-use demand. The third stage consisted of primary research with participants across the value chain to validate assumptions and refine estimates. In the fourth stage, market size was estimated using top-down and bottom-up approaches, followed by data triangulation. Finally, the forecast was developed using a factor-based model and subjected to internal review for consistency across segments, regions and countries.
Secondary Research
Secondary research drew on sources specific to the fluorochemicals, electronic specialty gases and contrast-media industries, including:
Industry associations: semiconductor and electronic materials associations (for example SEMI and the Semiconductor Industry Association), compressed gas and industrial gas associations, and fluorochemical producer bodies.
Government and regulatory bodies: environmental agencies publishing greenhouse gas inventories and facility-level emission data (such as the U.S. EPA Greenhouse Gas Reporting Program), the European Commission and the European Chemicals Agency, drug regulators (U.S. FDA and European Medicines Agency) for contrast agent approvals and labels, and geological surveys for fluorspar supply.
Company filings: annual reports, investor presentations, sustainability reports and press releases of industrial gas companies, fluorochemical producers, electronic materials suppliers and contrast-agent manufacturers.
Trade journals and technical literature: semiconductor process and materials publications, journals on plasma chemistry and fluorine chemistry, and medical imaging literature on contrast-enhanced ultrasound.
Paid databases: trade statistics by harmonised system code, company financial databases, semiconductor fab capacity and equipment spending trackers, and patent databases.
Primary Research
Primary research was conducted through in-depth interviews and structured discussions with industry participants to validate secondary findings, fill information gaps and test forecast assumptions. On the supply side, respondents included executives, product managers and technical specialists at fluorochemical producers, electronic specialty gas manufacturers, gas purifiers and fillers, and distributors. On the demand side, respondents included process engineers and procurement managers at semiconductor fabs and foundries, materials managers at contrast-agent manufacturers, hospital procurement and imaging specialists, and buyers in refrigerant and specialty applications. Objectives included understanding pricing by grade and region, qualification cycles, consumption intensity per wafer start, substitution trends, emissions abatement practices and capacity expansion plans.
Market Size Estimation
Top-down approach: The overall electronic specialty gases and medical contrast-agent markets were used as starting points, and the share attributable to octafluoropropane was derived from product-mix analysis, company disclosures and expert input. The resulting global value was then allocated across applications, purity grades and regions using consumption patterns and installed capacity.
Bottom-up approach: Country-level demand was built from semiconductor wafer capacity and utilisation, estimated C3F8 consumption per unit of capacity, the number of contrast-enhanced ultrasound procedures and associated perflutren usage, and volumes consumed in other applications. Volumes were multiplied by grade- and region-specific average selling prices and aggregated to regional and global totals.
Data triangulation: The results of both approaches were compared and reconciled with supplier revenue analysis, trade data and primary interview inputs. Differences were investigated and resolved to arrive at final estimates that are consistent across segments, regions and countries.
Forecasting Methodology
The forecast was developed using a factor-based model that links demand to its underlying drivers. Factors considered include semiconductor fab capacity additions and utilisation, technology node migration and etch-step intensity, public incentive programmes, emissions regulations and abatement adoption, substitution by alternative etch and cleaning chemistries, growth in echocardiography and contrast-enhanced ultrasound procedures, healthcare spending, average selling price trends by purity grade, feedstock (fluorspar and hydrogen fluoride) availability, and macroeconomic indicators. Historical relationships between these factors and market value were used to project each segment, and the projections were validated with industry experts.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024.
Base year: 2025.
Forecast period: 2026–2032; CAGR reported for 2026–2032.
Currency: All values are expressed in USD Million at constant 2025 exchange rates.
Assumptions and Limitations
Global semiconductor fabrication capacity continues to expand over the forecast period in line with announced projects, without a prolonged downturn beyond normal industry cycles.
Regulations on perfluorocarbons tighten reporting, abatement and emission requirements but do not prohibit the use of C3F8 in semiconductor manufacturing or medical applications during the forecast period.
No major disruption occurs in the supply of fluorspar, hydrogen fluoride or other key feedstocks beyond what was observed in the historic period.
Average selling prices remain broadly stable in real terms, with a premium maintained for 5N & Above grades.
Exchange rates are held constant at 2025 levels; inflation effects are not separately modelled.
Limited public disclosure of C3F8-specific revenue by suppliers, many of which report electronic gases or fluorochemicals as aggregated segments, introduces estimation uncertainty, particularly at country level and for smaller markets.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global octafluoropropane market is moderately consolidated. Supply of electronic-grade C3F8 to leading-edge fabs is concentrated among a small group of global industrial gas and electronic materials companies with established purification, analytical and cylinder logistics capabilities, while a larger number of regional fluorochemical and specialty gas producers compete in the Below 5N grade and in domestic markets, particularly in China. Pharmaceutical-grade supply for perflutren contrast agents is a specialised niche served under long-term qualified supply arrangements.
Competition is based primarily on product purity and lot-to-lot consistency, security and continuity of supply, proximity to customer fabs, technical service and price. Long qualification cycles at semiconductor fabs and GMP requirements in pharmaceutical applications create high switching costs and favour incumbents. At the same time, state-supported Chinese producers are adding high-purity C3F8 capacity under import-substitution policies, increasing price competition in Asia Pacific, while global players are responding with investments in regional production, acquisitions in Asian electronics hubs and bundled gas supply and management services.
Key Player Positioning
Leaders: Linde, Air Liquide, Merck KGaA (EMD Electronics) and Nippon Sanso Holdings lead the market through broad electronic specialty gas portfolios, global production and distribution networks, long-term supply contracts with the world's largest chipmakers and on-site presence at major fab clusters. Each offers octafluoropropane alongside a full range of etch, clean and deposition gases, allowing it to serve customers as a single strategic supplier.
Challengers: Resonac, Messer, PERIC Special Gases and Guangdong Huate Gas hold strong positions in specific regions or product areas. Resonac brings deep fluorine chemistry and electronic gas expertise from Japan; Messer offers 5N-grade C3F8 and is expanding in Southeast Asian electronics hubs; PERIC and Huate are scaling high-purity fluorocarbon capacity, including C3F8, to capture domestic Chinese demand under localisation policies.
Niche players: TEMC, EFC Gases & Advanced Materials and HaloPolymer serve specific customer groups or geographies. TEMC supplies Korean memory and display makers, EFC provides a Western supply channel for high-purity C3F8 through its exclusive arrangement with 3M, and HaloPolymer supplies R-218 grades primarily to Russian and regional markets.
Linde plc
Linde is the world's largest industrial gas company by sales, supplying atmospheric, process and specialty gases together with engineering services. It serves semiconductor fabs through on-site air separation, bulk gases and electronic specialty gases, including through its Taiwanese joint venture Linde LienHwa. Octafluoropropane is offered as a standard product (Octafluoropropane 4.0 / R218) and within the SPECTRA EM electronic materials line, which covers C3F8 alongside CF4, C4F8, NF3 and other etch and clean gases.
Latest reported revenue: USD 34.0 billion (FY2025).
Relevant products: Octafluoropropane 4.0 / R218; SPECTRA EM electronic materials (C3F8, CF4, C4F8, NF3, SF6, HBr and others); ultra-high-purity bulk gases for fabs.
Strategy: Wins long-term on-site supply contracts at leading-edge fabs and bundles bulk gases with electronic specialty gases (SPECTRA EM) to lock in fab customers in Asia and the US.
Air Liquide S.A.
Air Liquide is a global leader in industrial gases, technologies and services for industry and healthcare. Its Electronics business supplies carrier gases, electronic specialty gases, including fluorocarbon etch and clean gases, and advanced precursors to semiconductor fabs worldwide, with distribution in the United States through Airgas. Octafluoropropane is supplied in Europe in N37 grade and in the United States as semiconductor-grade R218 through Airgas.
Latest reported revenue: EUR 26.94 billion (FY2025), approx. USD 30.4 billion.
Relevant products: Octafluoropropane N37; semiconductor-grade R218 (Airgas); electronic specialty gases and ALOHA advanced precursors.
Strategy: Pairs long-term on-site fab supply with high-margin electronic specialty gases and advanced materials, and expands in Asian chip hubs (Korea, Taiwan) via investment and M&A.
Merck KGaA (EMD Electronics)
Merck KGaA is a science and technology group operating in Healthcare, Life Science and Electronics. Its Electronics sector, strengthened by the 2019 acquisition of Versum Materials, supplies specialty gases, thin-film precursors, patterning and formulation materials to chipmakers. It markets octafluoropropane as a chamber-cleaning gas under the MEGA-CLASS brand, with supply across the United States, South Korea, China, Taiwan, Japan and Europe, and operates one of the world's largest integrated specialty gas facilities in Hometown, Pennsylvania.
Latest reported revenue: EUR 21.10 billion (FY2025), approx. USD 23.9 billion; Electronics sector EUR 3.52 billion.
Relevant products: C3F8 MEGA-CLASS octafluoropropane for chamber cleaning; NF3, WF6 and other fluorinated etch and clean gases; precursors and gas delivery systems.
Strategy: Positions as an electronics materials 'solutions' partner with a broad gas-plus-materials portfolio and localized megasites near major fabs in Taiwan and the US.
Nippon Sanso Holdings Corporation
Nippon Sanso Holdings is Japan's largest industrial gas group and an affiliate of Mitsubishi Chemical Group, with operations in Japan, the United States (Nippon Sanso MATHESON), Europe and Asia-Oceania. It is a major supplier of electronic gases, gas delivery equipment and on-site supply to semiconductor fabs, and offers octafluoropropane (Halocarbon 218) in ULSI-grade purity for semiconductor applications.
Latest reported revenue: JPY 1,359.6 billion (FY ended March 2026), approx. USD 9.1 billion.
Relevant products: Halocarbon 218 (C3F8) ULSI grade; electronic specialty and bulk gases; gas purifiers and delivery systems.
Strategy: Leverages its Japanese electronics heritage and US/European platforms to grow electronic-materials gases and equipment, under a single global Nippon Sanso brand.
Resonac Holdings Corporation
Resonac was formed in January 2023 through the integration of Showa Denko and Showa Denko Materials (formerly Hitachi Chemical) and has a strong semiconductor materials franchise. The company is a long-established Japanese producer of high-purity fluorinated electronic gases, and Showa Denko developed and patented processes for the production and purification of octafluoropropane for semiconductor use.
Latest reported revenue: JPY 1,347.1 billion (FY2025), approx. USD 9.0 billion.
Relevant products: High-purity fluorocarbon etching gases, high-purity HF gas and other electronic gases; proprietary C3F8 production and purification technology.
Strategy: Concentrates resources on semiconductor materials and builds dual-site production in Japan for critical etching gases to secure supply for leading-edge fabs.
Messer SE & Co. KGaA
Messer is the largest privately held industrial gas company, with operations in Europe, Asia and the Americas. Its specialty gases business supplies high-purity and electronic gases, including octafluoropropane 5.0 (99.999% minimum) for silicon dioxide plasma etching, reactive ion etching and chamber cleaning, as well as R-218 for refrigeration applications.
Latest reported revenue: EUR 4.5 billion (FY2025), approx. USD 5.1 billion.
Relevant products: Octafluoropropane 5.0 for plasma etching and chamber cleaning; R-218 refrigerant; wider specialty and electronic gases portfolio.
Strategy: Expands specialty and electronic gas reach through bolt-on acquisitions in Asian electronics hubs while keeping a high-purity (5N) catalogue for etch gases.
PERIC Special Gases Co., Ltd.
PERIC Special Gases, a subsidiary of China State Shipbuilding Corporation's 718th Research Institute listed on the Shanghai STAR Market, is China's largest producer of nitrogen trifluoride and tungsten hexafluoride. Its fluorocarbon gas line includes octafluoropropane for thin-film deposition and chamber cleaning in high-stack memory, advanced logic and display manufacturing, and it has added high-purity C3F8 capacity targeting 5N and above grades for Chinese fabs.
Latest reported revenue: CNY 2.26 billion (FY2025), approx. USD 314 million.
Relevant products: Octafluoropropane (high-purity, up to 5N5); NF3, WF6, mixed and inorganic electronic gases; triflic acid series products.
Strategy: Pursues import substitution in China by scaling large NF3 and WF6 capacity and extending into high-purity fluorocarbon etch and clean gases, including C3F8, for domestic memory and logic fabs.
Guangdong Huate Gas Co., Ltd.
Huate Gas is a Chinese specialty gas supplier offering electronic specialty gases, including fluorocarbons such as CF4, C2F6, C4F8, CHF3 and C4F6, lithography laser gas mixtures and industrial gases, with production bases in Foshan and Jiujiang and a new base under development in Jiangsu. The company has developed rectification and purification capability for octafluoropropane and is expanding high-purity fluorocarbon capacity to serve domestic semiconductor customers.
Latest reported revenue: CNY 1.42 billion (FY2025), approx. USD 197 million.
Relevant products: High-purity fluorocarbons (CF4, C2F6, C4F8, CHF3, C4F6) and octafluoropropane purification; lithography gas mixtures; industrial gases.
Strategy: Building a one-stop domestic electronic gas platform, localising fluorocarbon etch gases and expanding capacity close to fab clusters through a three-base network.
TEMC Co., Ltd.
TEMC is a South Korean manufacturer of specialty gases for semiconductors and displays, including rare gases, excimer laser gases, carbonyl sulphide, diborane and fluorocarbon etch gases. Its customers include Samsung Electronics, SK hynix and DB HiTek. The company supplies 4N-grade C3F8 for dry etching with trans-filling capacity of 200 tonnes per year.
Latest reported revenue: KRW 310.2 billion (FY2024, consolidated), approx. USD 218 million.
Relevant products: C3F8 4N; CHF3 5N, C4F8 5N, C4F6, COS, 11BF3, high-purity neon and excimer laser gases.
Strategy: Localizes synthetic and rare semiconductor gases in Korea to replace imports, deepening ties with Samsung and SK hynix.
EFC Gases & Advanced Materials
EFC Gases & Advanced Materials, formerly Electronic Fluorocarbons, is a U.S. supplier of high-purity specialty, fluorocarbon and rare gases, advanced materials and gas recovery systems, with semiconductors accounting for a large part of its sales. It holds a global exclusive supply agreement with 3M for C3F8, making it an important Western channel for the gas. The company was acquired by Element Solutions Inc in January 2026.
Latest reported revenue: Not separately disclosed; part of Element Solutions Inc since January 2026.
Relevant products: High-purity C3F8 (exclusive 3M supply); other fluorocarbons, rare gases (xenon, krypton, neon) and gas recovery systems; North American distribution of Solvay Solvaclean.
Strategy: Secures exclusive supply and distribution rights and adds purification, recovery and recycling services for U.S. semiconductor customers, now backed by Element Solutions.
JSC HaloPolymer
HaloPolymer is Russia's largest fluorochemical producer, manufacturing fluoropolymers, fluoroelastomers, refrigerants, special fluorinated gases and inorganic fluorine chemicals at its Perm and Kirovo-Chepetsk sites. It produces R-218 (octafluoropropane) in two grades, primarily for domestic and regional markets.
Latest reported revenue: Not publicly disclosed (privately held).
Relevant products: R-218 octafluoropropane (Grade A 99.96% minimum; Grade B 99.0% minimum); fluoropolymers, refrigerants and perfluorinated fluids.
Strategy: Operates as a vertically integrated domestic fluorochemical producer supplying R-218 mainly to Russian and regional markets.
Competitor Dashboard
The dashboard below rates each profiled company on four competitive parameters on a scale of Low, Medium, High and Very High, based on the breadth of its fluorinated gas and electronic specialty gas portfolio, its geographic manufacturing and distribution footprint, the extent of its partnerships with chipmakers, distributors and technology partners, and its experience in fluorine chemistry and high-purity gas supply.
Threat of New Entrants – Low
High capital and technical requirements for fluorination, purification to 5N and above, and analytical certification.
Lengthy qualification cycles at semiconductor fabs and GMP requirements for pharmaceutical grades favour incumbents.
Access to secure fluorspar and hydrogen fluoride feedstock is a barrier, although state-supported entrants in China are increasing capacity.
Bargaining Power of Suppliers – Medium
Fluorspar and hydrogen fluoride supply is geographically concentrated, giving upstream suppliers pricing leverage in tight markets.
Many leading C3F8 producers are vertically integrated into hydrogen fluoride or fluorochemical intermediates, which reduces supplier power.
Specialised cylinders, valves and analytical equipment come from a limited supplier base.
Bargaining Power of Buyers – Medium
Large chipmakers buy significant volumes and run competitive multi-sourcing tenders.
Switching costs are high after qualification, which limits buyers' ability to change suppliers quickly.
Contrast-agent manufacturers are few in number but require pharmaceutical-grade consistency, balancing their negotiating strength.
Threat of Substitutes – Medium
NF3 remote plasma cleaning has displaced perfluorocarbons in many chamber-cleaning applications.
Alternative fluorocarbons (c-C4F8, C4F6, C5F8, CHF3) compete in specific etch steps; lower-GWP alternatives are under development.
In ultrasound contrast, sulphur hexafluoride-based microbubble agents compete with perflutren products in several markets.
Competitive Rivalry – Medium
The market is moderately consolidated, with Japanese, Korean, Chinese, European and U.S. producers competing on purity, reliability and service.
Chinese producers are expanding capacity and competing on price in Asia Pacific.
Differentiation through purity, supply security and technical service moderates price-based competition in advanced-node supply.
Threat of New Entrants: Low; Capital intensity, purification know-how, long qualification cycles.
Bargaining Power of Suppliers: Medium; Concentrated fluorspar/HF supply offset by producer integration.
Bargaining Power of Buyers: Medium; Large chipmaker volumes offset by high switching costs.
Threat of Substitutes: Medium; NF3 cleaning, alternative fluorocarbons, SF6-based contrast agents.
Competitive Rivalry: Medium; Moderately consolidated market; price competition rising in Asia.
Market estimates by geography (2032)
InsightAsia Pacific leads with $203.26M by 2032, while Middle East & Africa is projected to grow fastest at a 6.2% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $17.09M | $20.66M | $23.98M | 3.4% | 9% |
| Europe | $12.00M | $14.43M | $16.66M | 3.3% | 7% |
| Asia Pacific | $130.59M | $168.41M | $203.26M | 4.5% | 81% |
| Latin America | $1.56M | $2.18M | $2.83M | 6.1% | 1% |
| Middle East & Africa | $3.12M | $4.37M | $5.68M | 6.2% | 2% |
| Total | $164.36M | $210.06M | $252.40M | 4.4% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$252.40M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Semiconductor Etching | $154.97M | 4.8% | 61% |
| Medical Imaging (Ultrasound Contrast) | $73.45M | 3.9% | 29% |
| Others | $23.98M | 3.4% | 9% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Octofluoropropane Market covering market dynamics, competitive landscape, and strategic outlook.
The Octofluoropropane Market market is projected to reach $252.40M by 2032, growing at 4.4% CAGR. The Semiconductor Etching segment holds the largest share.
The Global Octofluoropropane Market is shaped by the investment cycle of the semiconductor industry, by healthcare demand for ultrasound contrast imaging, and by an increasingly demanding regulatory environment for fluorinated greenhouse gases. This chapter assesses the macro and micro factors influencing the market, followed by the main drivers, restraints, opportunities, trends and challenges. The impact scores presented in the growth factor analysis below are analyst assessments based on secondary and primary research, scored out of 10 for each period, where higher scores indicate a stronger impact in the stated direction.
Expansion of Global Semiconductor Fabrication Capacity
Semiconductor manufacturing is the single largest source of demand for octafluoropropane, and the industry is in a period of sustained capacity expansion. Governments have committed unprecedented public funding to domestic chip production: the U.S. CHIPS and Science Act of 2022 provided about USD 52.7 billion for semiconductor manufacturing, research and workforce development, the European Chips Act that entered into force in September 2023 aims to mobilise more than EUR 43 billion of public and private investment, Japan has subsidised new fabs operated by TSMC's JASM subsidiary in Kumamoto and by Rapidus in Hokkaido, and China launched the third phase of its national integrated circuit investment fund in 2024 with registered capital of RMB 344 billion. Each new fab requires qualified, continuous supply of electronic specialty gases, including fluorocarbon etchants such as C3F8 for dielectric etching and chamber cleaning. Because gas consumption scales with wafer starts and with the number of etch and clean steps, capacity additions translate directly into incremental gas volume. This is reflected in the Semiconductor Etching segment, which is projected to grow from USD 115.86 Million in 2025 to USD 154.97 Million by 2032, at a CAGR of 4.15% over 2026–2032.
Rising Device Complexity and Etch Intensity
The migration to advanced logic nodes, 3D NAND with ever-higher layer counts, and high-bandwidth DRAM used in artificial intelligence accelerators has substantially increased the number of plasma etch and deposition steps per wafer. Dielectric etching of high-aspect-ratio contacts, vias and trenches relies on carefully balanced fluorocarbon chemistries, in which C3F8 is used alongside other perfluorocarbons to control the ratio of fluorine radicals to polymer-forming species and thus selectivity and profile. More deposition steps also increase the frequency of in-situ chamber cleaning, an application in which C3F8 has been adopted as a lower-emission alternative to C2F6 because of its higher dissociation efficiency. At the same time, smaller feature sizes have raised purity requirements, as trace moisture, oxygen, metals and other fluorocarbon impurities can cause yield loss. This favours the 5N & Above grade, which is expected to grow at 4.23% compared with 2.83% for Below 5N material.
Growing Use of Ultrasound Contrast Agents in Cardiovascular Diagnostics
Perflutren-based ultrasound enhancing agents, such as lipid-encapsulated and protein-encapsulated microsphere products approved by the U.S. Food and Drug Administration and the European Medicines Agency, use octafluoropropane as the gas core of microbubbles that strongly reflect ultrasound. They are used to opacify the left ventricle and improve endocardial border delineation in patients with suboptimal echocardiograms, and their use is expanding in contrast-enhanced ultrasound for liver lesion characterisation and other indications. Cardiovascular disease remains the leading cause of death globally, and ageing populations are increasing the volume of echocardiography procedures, particularly in North America, Europe, Japan and China. Contrast echocardiography is radiation-free and less costly than many alternative imaging modalities, supporting its adoption in both hospital and outpatient settings. The Medical Imaging (Ultrasound Contrast) segment is therefore a steady growth contributor, projected to grow from USD 57.93 Million in 2025 to USD 73.45 Million by 2032, at a CAGR of 3.38% over 2026–2032.
Supply-Chain Localisation and Security of Supply
Export restrictions and geopolitical tension have made security of supply for critical semiconductor materials a strategic priority. Japan's 2019 tightening of export controls on fluorinated polyimide, photoresists and hydrogen fluoride to South Korea, which was not fully reversed until 2023, accelerated domestic development of fluorinated electronic materials in Korea. U.S. export controls on advanced semiconductor technology introduced from October 2022, and China's subsequent controls on certain critical minerals, have encouraged chipmakers in all major regions to dual-source and to localise specialty gas supply. This has prompted investments by industrial gas majors and regional producers in purification, filling and analytical facilities close to new fabs in the United States, Japan, Korea, Taiwan, China, India and Europe. Localisation increases the number of qualified supply points and the inventory held in the system, supports premium pricing for proven high-purity material and creates opportunities for new entrants with competitive fluorination technology.
New Fabs in Emerging Semiconductor Hubs
India's Semiconductor Mission, with incentive outlays approved in 2021 and the first fab and assembly projects approved in Gujarat and Assam since 2023, along with projects in Southeast Asia, the Middle East and Mexico, is creating new demand centres that require local electronic gas supply. India is the fastest-growing country market in this study (CAGR 7.23%), and the UAE (CAGR 6.91%) and Saudi Arabia (CAGR 5.78%) are also expanding quickly from a low base. Early-moving suppliers can secure long-term supply agreements and on-site positions.
Ultra-High-Purity and Value-Added Supply Services
Advanced logic and memory fabs are tightening specifications for metals, moisture and fluorocarbon impurities, opening room for 6N-class products, advanced cylinder passivation, real-time analytical certification and bulk specialty gas delivery systems. Suppliers that bundle C3F8 with gas management, abatement support and emissions reporting can differentiate on total cost of ownership and lock in multi-year contracts.
Broader Clinical Use of Contrast-Enhanced Ultrasound
Growing clinical acceptance of contrast-enhanced ultrasound in liver imaging, paediatric applications, vascular imaging and intensive care, together with expansion of echocardiography capacity in China, India, Latin America and the Middle East, offers growth for pharmaceutical-grade perflutren. Suppliers able to meet pharmacopoeial and Good Manufacturing Practice (GMP) requirements and to support regulatory filings for contrast-agent manufacturers can build durable, high-margin relationships.
Stringent Regulation of High-GWP Perfluorocarbons
C3F8 is a potent and extremely long-lived greenhouse gas. It is reported under national greenhouse gas inventories submitted to the UNFCCC, under facility-level reporting rules such as Subpart I of the U.S. EPA Greenhouse Gas Reporting Program for electronics manufacturing, and is covered by the EU F-gas Regulation (EU) 2024/573. The universal PFAS restriction proposal submitted to the European Chemicals Agency in 2023 includes fluorinated gases within its scope, creating long-term uncertainty for producers and users in Europe. Compliance requires investment in point-of-use abatement, emission monitoring and reporting, and raises the total cost of using the gas, which may limit growth in some applications and regions.
Substitution by Alternative Chemistries
In chamber cleaning, many fabs have moved to remote plasma cleaning with nitrogen trifluoride, which achieves very high utilisation and low perfluorocarbon emissions. In etching, the choice of fluorocarbon depends on the process, and higher-carbon or unsaturated fluorocarbons such as c-C4F8, C4F6 and C5F8 are frequently preferred for high-selectivity applications. Research into lower-GWP etch gases, including hydrofluoroolefins and fluorinated ethers, could further reduce the role of C3F8 over the long term, constraining growth in the Below 5N grade in particular.
Feedstock Concentration and Cost Volatility
Octafluoropropane production depends on fluorspar and anhydrous hydrogen fluoride, as well as on chlorinated or fluorinated hydrocarbon intermediates. Global fluorspar mining is concentrated in a small number of countries, with China accounting for the majority of output, and Chinese export policy, environmental inspections and energy costs have periodically affected availability and pricing. Purification to 5N and above is energy-intensive and requires specialised distillation and analytical capabilities, adding cost and limiting the number of qualified producers.
Challenge: Qualification Barriers and Long Approval Cycles
Qualification of a new gas source at a semiconductor fab can take many months and requires extensive analytical and process testing, while pharmaceutical-grade supply must satisfy drug-master-file and GMP requirements. These barriers protect incumbents but slow the entry of new capacity and can create temporary tightness when demand rises quickly.
Challenge: Cyclicality of Semiconductor Demand
The semiconductor industry is cyclical; memory downturns, such as that experienced in 2023, reduce fab utilisation and gas consumption. Although structural demand from artificial intelligence, electric vehicles and connectivity supports long-term growth, short-term inventory corrections can affect volumes and pricing for electronic-grade C3F8.
Trend: Emission Abatement and Process Optimisation
Semiconductor manufacturers have adopted voluntary and regulatory targets for perfluorocarbon emission reduction, and many have announced net-zero or science-based climate targets. Point-of-use abatement systems, process recipe optimisation and gas recovery are being deployed widely, reducing emissions per unit of gas consumed and allowing continued use of C3F8 in critical processes.
Trend: Regionalisation of Electronic Specialty Gas Production
Industrial gas companies and fluorochemical producers in Japan, Korea and China are expanding electronic gas capacity and building facilities near customer clusters, while Chinese producers are increasing their share of domestic supply as local chipmakers seek domestic qualification. This is reshaping trade flows and competitive dynamics, particularly in Asia Pacific.
The octafluoropropane value chain comprises four principal stages:
Raw materials and inputs: Fluorspar (calcium fluoride) is converted to anhydrous hydrogen fluoride, which, together with hydrocarbon or chlorofluorocarbon intermediates such as propane derivatives or hexafluoropropylene, provides the fluorine and carbon backbone for synthesis. Elemental fluorine and cobalt trifluoride are used in some production routes. Feedstock security and cost are key determinants of producer competitiveness.
Manufacturing and purification: C3F8 is produced by electrochemical fluorination, direct fluorination or catalytic fluorination of partially fluorinated intermediates, followed by multi-stage distillation, adsorption and purification to remove moisture, acids, air gases and other fluorocarbons. Electronic grades are purified to 5N (99.999%) or higher and certified by gas chromatography, FTIR and trace-metal analysis; pharmaceutical grades are produced under GMP-aligned controls.
Distribution and channels: Purified gas is filled into passivated cylinders, ton units and ISO containers. Supply reaches end users directly from producers, through industrial gas majors that purify and repackage gas for semiconductor fabs, and through specialty gas distributors. Logistics must comply with dangerous-goods regulations for compressed gases, and fabs often use bulk specialty gas systems and gas cabinet management services.
End users: Semiconductor fabs, foundries and integrated device manufacturers (etching and chamber cleaning), display and MEMS manufacturers, pharmaceutical companies producing perflutren microsphere contrast agents, ophthalmic device companies supplying intraocular gases, and refrigerant blenders and specialty industrial users.
Octafluoropropane is regulated as a fluorinated greenhouse gas, as an industrial chemical and, in pharmaceutical use, as a component of approved drug products. Key regulations by major region are summarised below.
Key strategic developments undertaken by the profiled companies since 2022, including product launches, mergers and acquisitions, partnerships and capacity expansions, are summarised below.
Aug 2026: Guangdong Huate Gas Co., Ltd.; Investment; Disclosed a private placement of up to CNY 700 million to build phase one of its Jiangsu (Nantong) semiconductor materials production base.
Jul 2026: Linde plc; Investment; Announced investment of about USD 1 billion in two new air separation units in Phoenix, Arizona, to supply two new fabs, while Linde LienHwa plans about USD 800 million of investment for new semiconductor and advanced packaging sites in Taiwan.
Jul 2026: Messer SE & Co. KGaA; Acquisition; Completed the acquisitions of WKS Group (Singapore/Malaysia) and Wipco Industrial near the Penang semiconductor hub, and signed an agreement for Kobewel Kogyo Gases, expanding in Southeast Asia.
Jun 2026: Resonac Holdings Corporation; Expansion; Announced additional high-purity HF etching gas production at its Tokuyama Plant, alongside Kawasaki, for advanced and cryogenic etching, with start-up within 2026.
Jan 2026: Air Liquide S.A.; Acquisition; Completed the acquisition of DIG Airgas in South Korea (announced August 2025), significantly expanding its Korean industrial and electronics gas business.
Jan 2026: Nippon Sanso Holdings Corporation; R&D Investment; Taiyo Nippon Sanso announced an Advanced Electronics Materials Development Building to develop new semiconductor process materials and equipment, due for completion in March 2027.
Jan 2026: PERIC Special Gases Co., Ltd.; Capacity Expansion; Completed a 100 tonnes per year high-purity octafluoropropane project with purity of up to 5N5, as reported by industry sources.
Jan 2026: EFC Gases & Advanced Materials; Acquisition; Acquired by Element Solutions Inc (agreement announced November 2025); now operates within the Specialties segment.
Dec 2025: Merck KGaA (EMD Electronics); Plant Inauguration; Inaugurated the EUR 500 million Kaohsiung Semiconductor Solutions megasite producing thin-film, formulation materials and specialty gases for AI logic and memory chips.
Dec 2025: Guangdong Huate Gas Co., Ltd.; Capacity Expansion; Completed sub-projects of its 1,764 tonnes per year semiconductor materials project, with capacity released gradually.
Sep 2025: Nippon Sanso Holdings Corporation; Rebranding; Announced the renaming of MATHESON to Nippon Sanso MATHESON from April 2026, unifying the group under a single global brand.
May 2025: Linde plc; Agreement / Expansion; New long-term agreement to build, own and operate an additional air separation unit and supply hydrogen at Samsung's Pyeongtaek semiconductor complex, with supply from mid-2026.
Apr 2025: TEMC Co., Ltd.; Expansion / Partnership; Completed an automated third plant, expanded diborane capacity for Samsung Electronics and co-developed neon recovery technology with SK hynix.
Jan 2025: PERIC Special Gases Co., Ltd.; New Plant; Commissioned its Hohhot subsidiary with 7,500 tonnes per year of high-purity NF3 and 10,000 tonnes per year of ultra-pure ammonia capacity.
Jul 2023: Air Liquide S.A.; Expansion; Announced new advanced materials centres across Asia, including Taiwan, South Korea, China and Singapore, to support semiconductor customers.
Apr 2023: Merck KGaA (EMD Electronics); Expansion; Announced an investment of about EUR 300 million to expand its Hometown, Pennsylvania specialty gases site.
Apr 2023: PERIC Special Gases Co., Ltd.; IPO / Expansion; Listed on the Shanghai STAR Market, with proceeds earmarked for capacity projects including a 3,250 tonnes per year NF3 project.
Feb 2023: Merck KGaA (EMD Electronics); Expansion; Broke ground on a specialty gases and semiconductor materials site in Kaohsiung, Taiwan, under its multi-billion-euro "Level Up" investment programme.
Jan 2023: Resonac Holdings Corporation; Restructuring; Showa Denko and Showa Denko Materials integrated and began operating under the Resonac name.
Jan 2023: TEMC Co., Ltd.; IPO; Listed on KOSDAQ, positioning itself as a localiser of semiconductor specialty gases in South Korea.
Dec 2022: EFC Gases & Advanced Materials; Partnership; Entered an exclusive North American distribution partnership with Solvay for Solvaclean fluorine-based chamber-cleaning gas.
Political
National semiconductor industrial policies in the U.S., EU, Japan, Korea, China and India drive demand for locally qualified electronic gases.
Export controls on semiconductor technology and critical minerals increase emphasis on supply security and regional sourcing.
Trade tensions influence the flow of fluorochemicals and fluorspar between China and other markets.
Economic
Semiconductor capital expenditure cycles determine near-term gas consumption and pricing.
Fluorspar, hydrogen fluoride and energy costs affect production economics, particularly for high-purity grades.
Healthcare spending growth supports demand for contrast-enhanced imaging in emerging markets.
Social
Ageing populations and rising cardiovascular disease prevalence increase echocardiography volumes.
Growing digitalisation, artificial intelligence and electric mobility raise demand for semiconductors.
Increased public awareness of PFAS and climate impacts shapes corporate procurement policies.
Technological
Advanced-node logic, 3D NAND and high-bandwidth memory increase etch-step intensity and purity requirements.
Development of low-GWP etch gases and NF3 remote plasma cleaning presents substitution risk.
Improvements in abatement, gas recovery and analytical certification support continued use of C3F8.
Environmental
C3F8 has a GWP of approximately 8,900 and an atmospheric lifetime of about 2,600 years, driving emission controls.
Semiconductor companies' net-zero and science-based targets encourage abatement and substitution.
Fluorspar mining and fluorochemical production face environmental compliance scrutiny.
Legal
F-gas, GHG reporting and PFAS-related regulations impose reporting and potential use restrictions.
Pharmaceutical regulations govern perflutren contrast agents, including labelling and safety requirements.
Dangerous-goods transport rules govern packaging and logistics of liquefied gases.
Profiles of 104 companies operating in the Octofluoropropane Market market, including revenue, employee count, and market positioning where available.
Showing 104 of 104 companies
Company Headquarters: Bad Soden, Germany Founded: 1898 Workforce: ~ 11,025 Company Working: Messer SE & Co. KGaA offers industrial, medical, and specialty gases for customers around the globe. The company supplies and manufactures oxygen, argon, nitrogen, carbon dioxide, helium, hydrogen, shielding gases for welding, medical, specialty, food, and many other gas mixtures via Messer North America, Inc. Messer North America, Inc. is part of the Messer SE & Co. KGaA. The company operates various subsidiaries, such as Messer Austria GmbH, Messer Ibérica de Gases S.A., Messer France, Messer Gases Ltd., and others. Messer SE & Co. KGaA operates in Europe, China, the Association of Southeast Asian Nations (ASEAN), and other countries.
Nippon Sanso Holdings is Japan's largest industrial-gas company and one of the global "Tier One" industrial-gas majors, operating a pure holding-company structure over four regional gas businesses — Nippon Sanso Corporation (Japan), Nippon Sanso Matheson (United States), Nippon Sanso Euro-Holding (Europe, formerly Nippon Gases, built on the ex-Praxair European business) and an Asia & Oceania platform anchored by Supagas and Coregas in Australia/New Zealand — plus the consumer-products Thermos brand. Roughly 70% of revenue is generated outside Japan. Its earnings model is the classic industrial-gas annuity: on-site and pipeline supply under long-term take-or-pay contracts, bulk liquid and cylinder distribution with high switching costs, and a fast-growing electronics franchise (specialty and electronic-material gases, total gas management, gas equipment). After four years of price-led margin expansion under "NS Vision 2026," management is now pursuing "Next Innovation 2030," targeting ≥17% core margins and ≥8% after-tax ROCE by FYE2030 while remaining controlled by Mitsubishi Chemical. --- ### Company's own description (latest results filing) In its FYE2026 consolidated results (11 May 2026), NSHD describes its operations as conducting gas businesses in Japan and overseas, mainly for customers in the steel, chemical and electronics industries, with production and sales bases for its main products in Japan, the United States, Europe and Asia & Oceania, and separately engaging in the manufacture and sale of housewares such as stainless-steel vacuum bottles. On that basis the group reports five segments: Japan, United States, Europe, Asia & Oceania, and Thermos. For the four gas segments, the company lists as main products and services: oxygen, nitrogen, argon, carbon dioxide, helium, hydrogen, acetylene, gas-related equipment, specialty gases (electronic-material gases, pure gases), electronics-related equipment and installation, compound-semiconductor manufacturing equipment, welding and cutting equipment, welding materials, plants and machinery, LPG and related equipment, medical gases (oxygen, nitrous oxide, etc.), medical equipment and stable isotopes. Thermos covers housewares and consumer goods. ### Independent characterisation NSHD is a regionally organised, vertically integrated industrial-gas producer and distributor with three distinct economic engines: 1. **Industrial gases (≈80%+ of profit).** Atmospheric gases (O₂, N₂, Ar) separated in air separation units (ASUs), plus CO₂/dry ice, hydrogen and syngas (HyCO), helium and acetylene. Electricity is the dominant variable cost of ASU production, which is why "price management" (pass-through of energy and inflation) has been the defining earnings driver since FYE2022. Distribution modes follow the industry's three-tier model: (a) on-site/pipeline supply under 10–20-year contracts with minimum-take provisions (steel, chemicals, refining, large fabs); (b) merchant/bulk liquid delivered by cryogenic tanker under multi-year contracts with tank rental; (c) packaged/cylinder gases with cylinder rental, hardgoods (welding consumables and equipment) and retail-style distribution. The packaged channel is particularly prominent in the US (Matheson's ~300-location network) and Australia (Supagas LPG plus Coregas). 2. **Electronics.** Electronic-material (specialty) gases for semiconductor, display and solar manufacturing; ultra-high-purity bulk gases for fabs; "Total Gas Supply Solutions"/Total Gas & Chemical Management services; gas cabinets, purifiers and installation projects (recognised on percentage-of-completion, hence lumpy); and compound-semiconductor deposition equipment. Electronics is a cross-segment business area rather than a reporting segment, and is a top-two strategic priority under Next Innovation 2030. 3. **Thermos (≈2.4% of revenue, ~19.6% segment margin).** A B2C consumer brand (vacuum bottles, mugs, sports bottles, frying pans, lunch boxes, cooler bags, apparel accessories brand "&ONDO"), operated largely in Japan and Asia, with equity-method affiliates contributing ~¥2.7–3.1bn per year. ### Revenue model mix The company does not disclose a product-versus-service-versus-rental split. Qualitatively: gas sales (product) dominate; recurring service-like revenue embedded in gas contracts includes facility fees, cylinder and tank rental; equipment & installation (E&I) is project revenue; homecare/respiratory services (Spain via Oximesa and Nippon Sanso Homecare España) are service revenue; licensing is immaterial. Subscription-style economics are present in the form of fixed facility charges in on-site contracts. ### Value-chain position NSHD sits mid-stream: it designs and builds its own ASUs (group engineering, strengthened by Italian plant-engineering investments Polaris and HYSYTECH), produces gases, owns logistics (tankers, cylinder fleets), and sells to industrial end users. It is also a merchant of LPG in Japan and Australia (purchased product, distributed).
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
3 interactive charts drawn from the Octofluoropropane Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Octofluoropropane Market By Purity
Global Octofluoropropane Market By Application
Global Octofluoropropane Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
